Abstract
1. 1. Single subcutaneous injections (0.5–10 mg/kg) or repeated oral administration (5 mg/kg, twice daily for 3 or 5 days) of the proposed anorexigenic peptide pyro-GLU-HIS-GLY-OH did not affect food intake in the mouse. 2. 2. Single intravenous injections (0.05–1 mg/kg) or daily intravenous injections (0.3–10 mg/kg, for 5 days) of pyro-GLU-HIS-GLY-OH did not affect food intake in the rat. 3. 3. These results, together with results obtained recently by other workers, indicate that pyro-GLU-HIS-GLY-OH does not have anorexigenic properties in rodents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
